Articles originaux

Bouvier AM, Arveux P, Baldi I, Bouvier V, Dabakuyo S, Daoulas M et al. Quels sont les délais de prise en charge des cancers en france ? Etude menée à partir des registres de cancers. Bull Epidemiol Hebd. 2013;43-44-45: 581-9.

Binder-Foucard F, Bossard N, Delafosse P, Belot A, Woronoff AS, Remontet L; French network of cancer registries (Francim). Cancer incidence and mortality in France over the 1980-2012 period: solid tumors. Rev Epidemiol Sante Publique. 2014;62:95-108. (Pubmed)

Pesson M, Volant A, Uguen A, Trillet K, De La Grange P, Aubry M, Daoulas M, Robaszkiewicz M, Le Gac G, Morel A, Simon B, Corcos L. A gene expression and pre-mRNA splicing signature that marks the adenoma-adenocarcinoma progression in colorectal cancer. PLoS One. 2014 Feb 6;9(2):e87761. (PubMed)

Desgrippes R, Bouvier V, Delafosse P, Robaszkiewicz M, Molinié F, Trétarre B, Lepage C, Faivre J, Jooste V, Bouvier AM. Management of rectal cancer in France in a well-defined population. Eur J Gastroenterol Hepatol. 2014 Jul;26(7):743-7. (PubMed)

Gattolliat CH, Uguen A, Pesson M, Trillet K, Simon B, Doucet L, Robaszkiewicz M, Corcos L. MicroRNA and targeted mRNA expression profiling analysis in human colorectal adenomas and adenocarcinomas. Eur J Cancer. 2015 Feb;51(3):409-20. (PubMed)

Allemani C, Weir HK, Carreira H, Harewood R, Spika D, Wang XS, Bannon F, Ahn JV, Johnson CJ, Bonaventure A, Marcos-Gragera R, Stiller C, Azevedo e Silva G, Chen WQ, Ogunbiyi OJ, Rachet B, Soeberg MJ, You H, Matsuda T, Bielska-Lasota M, Storm H, Tucker TC, Coleman MP; CONCORD Working Group. Global surveillance of cancer survival 1995–2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet 2015; 385: 977-1010. (PubMed)

Arnachellum R, Cariou M, Nousbaum JB, Jezequel J, Le Reste JY, Robaszkiewicz M. Pancreatic adenocarcinoma in the Finistere department, France, between 2002 and 2011 (1002 cases): population characteristics, treatment and survival. Pancreas. 2016;45:953-60 (Pubmed)

 

ETUDES EUROCARE

De Angelis R, Sant M, Coleman MP, Francisci S, Baili P, Pierannunzio D, et al.; EUROCARE-5 Working Group. Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE–5-a population-based study. Lancet Oncol. 2014;15:23-34. (Pubmed)

Minicozzi P, Bouvier AM, Faivre J, Sant M; Study working group. Management of rectal cancers in relation to treatment guidelines: a population-based study comparing Italian and French patients. Dig Liver Dis. 2014;46:645-51. (Pubmed)

Rossi S, Baili P, Capocaccia R, Caldora M, Carrani E, Minicozzi P, et al. ; EUROCARE-5 Working Group. The EUROCARE-5 study on cancer survival in Europe 1999-2007: Database, quality checks and statistical analysis methods.Eur J Cancer. 2015;51:2104-2119. (Pubmed)

Baili P, Di Salvo F, Marcos-Gragera R, Siesling S, Mallone S, Santaquilani M, et al.; EUROCARE-5 Working Group. Age and case mix-standardised survival for all cancer patients in Europe 1999-2007: Results of EUROCARE-5, a population-based study. Eur J Cancer. 2015;51:2120-2129. (Pubmed)

Gatta G, Botta L, Sánchez MJ, Anderson LA, Pierannunzio D, Licitra L; EUROCARE Working Group. Prognoses and improvement for head and neck cancers diagnosed in Europe in early 2000s: The EUROCARE-5 population-based study. Eur J Cancer. 2015;51:2130-2143. (Pubmed)

Anderson LA, Tavilla A, Brenner H, Luttmann S, Navarro C, Gavin AT, et al.; EUROCARE-5 Working Group . Survival for oesophageal, stomach and small intestine cancers in Europe 1999-2007: Results from EUROCARE-5. Eur J Cancer. 2015;51:2144-2157. (Pubmed)

Holleczek B, Rossi S, Domenic A, Innos K, Minicozzi P, Francisci Set al.; EUROCARE-5 Working Group. On-going improvement and persistent differences in the survival for patients with colon and rectum cancer across Europe 1999-2007 – Results from the EUROCARE-5 study. Eur J Cancer. 2015;51:2158-2168. (Pubmed)

Lepage C, Capocaccia R, Hackl M, Lemmens V, Molina E, Pierannunzio D, Sant M, Trama A, Faivre J; EUROCARE-5 Working Group. Survival in patients with primary liver cancer, gallbladder and extrahepatic biliary tract cancer and pancreatic cancer in Europe 1999-2007: Results of EUROCARE-5. Eur J Cancer. 2015 ;51:2169-2178. (Pubmed)

Crocetti E, Mallone S, Robsahm TE, Gavin A, Agius D, Ardanaz E, et al.; EUROCARE-5 Working Group. Survival of patients with skin melanoma in Europe increases further: Results of the EUROCARE-5 study. Eur J Cancer. 2015;51:2179-2190. (Pubmed)

Sant M, Chirlaque Lopez MD, Agresti R, Sánchez Pérez MJ, Holleczek B, Bielska-Lasota M,et al. ; EUROCARE-5 Working Group. Survival of women with cancers of breast and genital organs in Europe 1999-2007: Results of the EUROCARE-5 study. Eur J Cancer. 2015;51:2191-2205. (Pubmed)

Trama A, Foschi R, Larrañaga N, Sant M, Fuentes-Raspall R, Serraino D, et al.; EUROCARE-5 Working Group. Survival of male genital cancers (prostate, testis and penis) in Europe 1999-2007: Results from the EUROCARE-5 study.Eur J Cancer. 2015 ;51:2206-2216. (Pubmed)

Marcos-Gragera R, Mallone S, Kiemeney LA, Vilardell L, Malats N, Allory Y, Sant M; EUROCARE-5 Working Group. Urinary tract cancer survival in Europe 1999-2007: Results of the population-based study EUROCARE-5. Eur J Cancer. 2015;51:2217-2230. (Pubmed)

Visser O, Ardanaz E, Botta L, Sant M, Tavilla A, Minicozzi P; EUROCARE-5 Working Group:.Survival of adults with primary malignant brain tumours in Europe; Results of the EUROCARE-5 study.  Eur J Cancer. 2015;51:2231-2241. (Pubmed)

Francisci S, Minicozzi P, Pierannunzio D, Ardanaz E, Eberle A, Grimsrud TK, et al. EUROCARE-5 Working Group. Survival patterns in lung and pleural cancer in Europe 1999-2007: Results from the EUROCARE-5 study. Eur J Cancer. 2015;51:2242-2253. (Pubmed)

De Angelis R,, Minicozzi P, Sant M, Dal Maso L, Brewster DH, Osca-Gelis G, et al. Survival variations by country and age for lymphoid and myeloid malignancies in Europe 2000-2007: Results of EUROCARE-5 population-based study.Eur J Cancer. 2015;51:2254-2268.(Pubmed)

Gatta G, Capocaccia R, Botta L, Mallone S, De Angelis R, Ardanaz E, et al. RARECAREnet working group. Burden and centralised treatment in Europe of rare tumours: results of RARECAREnet-a population-based study. Lancet Oncol. 2017; 4. pii: S1470-2045 (Pubmed)

 

.

Dernière modification le 23 juillet 2017

Retour à la page Publications